FDA 510(k) · VitalConnect

K183078: VitalConnect Platform, VitalPatch Biosensor (Vitalconnect, Inc.)

Vitalconnect, Inc. received FDA 510(k) K183078 for VitalConnect Platform, VitalPatch Biosensor, with a decision date of Mar 7, 2019 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K183078FDA summary or statement (PDF)

FDA facts

Official fields for K183078
FDA numberK183078
Pathway510(k)
ApplicantVitalconnect, Inc.
Device nameVitalConnect Platform, VitalPatch Biosensor
Product codeDRG: Transmitters And Receivers, Physiological Signal, Radiofrequency
Regulation (21 CFR)870.2910
Device classClass 2
Date receivedNov 5, 2018
Decision dateMar 7, 2019
DecisionSubstantially Equivalent (SESE)
510(k) typeTraditional

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

The VitalConnect Platform is a wireless remote monitoring system intended for use by healthcare professionals for continuous collection of physiological data in home and healthcare settings. This can include heart rate, electrocardiography (ECG), heart rate variability, R-R interval, respiratory rate, body temperature, skin temperature, activity (including step count), and posture (body position relative to gravity including fall). Data are transmitted wirelessly from the VitalConnect Biosensor for storage and analysis. The VitalConnect Platform can include the ability to notify healthcare professionals when physiological data fall outside selected parameters. The device is intended for use on general care patients who are 18 years of age or older as a general patient monitor, to provide physiological information. The data from the VitalConnect Platform are intended for use by healthcare professionals as an aid to diagnosis and treatment. The device is not intended for use on critical care patients.

Extracted automatically from FDA's 510(k) summary. It can contain extraction errors and is not a verified quote. Read the wording in the FDA PDF before relying on it.

Predicates parsed from FDA documents

FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.

  • K163453 VitalPatch® VitalConnect Platform (VitalConnect)

Later records that cite K183078

  • K242018 UbiqVue™ 2A Multi-parameter System (UX2550) (LifeSignals, Nov 12, 2024, DRG)
  • K212153 Biobeat Platform, BB-613WP Patch (Biobeat, Mar 25, 2022, DQA)
  • K190916 VitalPatch 7D Biosensor - single, VitalPatch 7D Biosensor - bag of 20 (VitalConnect, Jun 7, 2019, DRG)

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code DRG is "Transmitters And Receivers, Physiological Signal, Radiofrequency", class 2, 21 CFR 870.2910.

Our labels for filtering: claim Remote / vital-sign monitoring, sensor Unknown. These are heuristics, not FDA fields.